Espinosa G - Search Results

1

COVID-19 and Behçet's disease: clinical case series.

Espinosa G, Araujo O, Amaro S, Bodro M, Moreno PJ, Moreno R, Ugarte A, Cervera R. Espinosa G, et al. Ann Rheum Dis. 2021 Mar;80(3):e41. doi: 10.1136/annrheumdis-2020-217778. Epub 2020 Jul 21. Ann Rheum Dis. 2021. PMID: 32719040 No abstract available.

2

Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.

Espinosa G, Font J, Tàssies D, Vidaller A, Deulofeu R, López-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter JC. Espinosa G, et al. Am J Med. 2002 Jan;112(1):37-43. doi: 10.1016/s0002-9343(01)01048-8. Am J Med. 2002. PMID: 11812405

3

Vascular involvement in Behçet's disease.

Espinosa G, Cervera R, Reverter JC, Tàssies D, Font J, Ingelmo M. Espinosa G, et al. Isr Med Assoc J. 2002 Aug;4(8):614-6. Isr Med Assoc J. 2002. PMID: 12183866 Free article. Review. No abstract available.

4

Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.

Espinosa G, Santos E, Cervera R, Piette JC, de la Red G, Gil V, Font J, Couch R, Ingelmo M, Asherson RA. Espinosa G, et al. Medicine (Baltimore). 2003 Mar;82(2):106-18. doi: 10.1097/00005792-200303000-00005. Medicine (Baltimore). 2003. PMID: 12640187 Free article. Review.

5

Antiphospholipid syndrome: pathogenic mechanisms.

Espinosa G, Cervera R, Font J, Shoenfeld Y. Espinosa G, et al. Autoimmun Rev. 2003 Mar;2(2):86-93. doi: 10.1016/s1568-9972(02)00144-1. Autoimmun Rev. 2003. PMID: 12848964 Review.

6

Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.

Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R, Reverter JC, Ingelmo M, Sanz G. Perez-Villa F, et al. Among authors: espinosa g. Arthritis Rheum. 2005 Jun 15;53(3):460-7. doi: 10.1002/art.21162. Arthritis Rheum. 2005. PMID: 15934103 Free article.

7

Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.

Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló S, Bucciarelli S, Ramos-Casals M, Ingelmo M, Asherson RA, Font J. Gómez-Puerta JA, et al. Among authors: espinosa g. Semin Arthritis Rheum. 2006 Apr;35(5):322-32. doi: 10.1016/j.semarthrit.2005.07.003. Semin Arthritis Rheum. 2006. PMID: 16616155 Review.

8

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.

Bucciarelli S, Espinosa G, Cervera R, Erkan D, Gómez-Puerta JA, Ramos-Casals M, Font J, Asherson RA; European Forum on Antiphospholipid Antibodies. Bucciarelli S, et al. Among authors: espinosa g. Arthritis Rheum. 2006 Aug;54(8):2568-76. doi: 10.1002/art.22018. Arthritis Rheum. 2006. PMID: 16868979 Free article.

9

Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.

Gómez-Puerta JA, Espinosa G, Miró JM, Sued O, Llibre JM, Cervera R, Font J. Gómez-Puerta JA, et al. Among authors: espinosa g. Isr Med Assoc J. 2006 Jul;8(7):513-4. Isr Med Assoc J. 2006. PMID: 16889175 Free article. No abstract available.

10

Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment.

Asherson RA, Espinosa G, Cervera R, Font J, Reverter JC. Asherson RA, et al. Among authors: espinosa g. J Clin Rheumatol. 2002 Jun;8(3):157-65. J Clin Rheumatol. 2002. PMID: 17041346

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

610 results

Search Page

Filters